Latest Market Data
Hang Seng Index
25,667.18
+129.11 (+0.51%)
HSCEI
9,257.62
+16.42 (+0.18%)
Hang Seng TECH Index
5,743.00
-2.74 (-0.05%)
Hang Seng HKEX Stock Connect China Enterprises Index
4,146.58
- (-)
MSCI China A 50 Connect Index
2,226.60
+9.82 (+0.44%)
HSI Volatility Index
22.93
-0.35 (-1.50%)
CSI 300 Index
4,149.04
+29.27 (+0.71%)
CES China120 Index
6,869.28
+8.61 (+0.13%)
USD/CNH Spot
7.1539
+0.0026 (+0.04%)
USD/INR Spot
86.3700
0.0000 (0.00%)
HKEX Bitcoin Reference Index
118,780.87
+310.19 (+0.26%)
HKEX Ether Reference Index
3,739.64
+145.31 (+4.04%)
CNH Gold Futures – Spot Price Index
-
- (-)
USD Gold Futures – Spot Price Index
-
- (-)
Refresh
Market Turnover
-






-
-
|
|
|
|
|
|
-
-
-
Loading

PURAPHARM CORPORATION LTD. (1498)

PURAPHARM (1498)

HK$0.455

-0.005 (-1.09%)

Prev. Close is the most recent non-zero closing value or settlement price.PREV. CLOSE
HK$0.460
Open price is the first traded price of the day. The opening price is reported after 09:20:00 HKT.OPEN
HK$0.460
TURNOVER
HK$47.15K
VOLUME
103.50K
MKT CAP
HK$180.13M
LOT SIZE
500
BID
HK$0.455
ASK
HK$0.465
EPS
-
P/E
-
DIV YIELD
-
INTRA-DAY 52W
High HK$0.460 HK$0.850
Low HK$0.450 HK$0.430
Information is available after the market opens and is delayed by at least 15 minutes.
Updated: 24 Jul 2025 15:12 HKT
  • 1 D
  • 1 M
  • 3 M
  • 6 M
  • YTD
  • 1 Y
  • 2 Y
  • 5 Y
  • 10 Y
1min
5min
15min
Hourly
Created with Highstock 6.2.0050K100K10:0011:0012:0013:0014:0015:0016:000.4450.4500.4550.4600.465Prev. Close
0.460
All charts use the last traded price or closing price.

COMPANY PROFILE

PuraPharm Corporation Ltd is an investment holding company principally engaged in the concentrated Chinese medicine granule (CCMG) businesses. The Company operates through five business segments. The China CCMG segment is mainly engaged in the production and sales of CCMG products in China. The Hong Kong CCMG segment is mainly engaged in the sales of CCMG products, excluding the sales through self-operated clinics in Hong Kong. The Chinese Healthcare Products segment is mainly engaged in the production and sales of healthcare products in Hong Kong and China. The Clinics segment is mainly engaged in the provision of Chinese medical diagnostic services and sales of CCMG products through self-operated clinics. The Plantation segment is mainly engaged in the plantation and trading of raw Chinese herbs, and the manufacture and sale of traditional Chinese medicine (TCM) decoction pieces. *
Please click to see notes of Issued Shares.Issued Shares (excluding treasury shares) 395,897,275 (as at 30 Jun 2025)
Industry Healthcare - Pharmaceuticals & Biotechnology - Pharmaceuticals Industry Classification (HSIC) is provided by Hang Seng Indexes Company Limited. Please see the . (HSIC)
Listing Date 8 Jul 2015
Financial Year Ends 31 Dec 2024
Chairman Chan Yu Ling, Abraham
Principal Office Unit 201-207, 2/F
Wireless Centre, Phase One
Hong Kong Science Park
Tai Po, NT, Hong Kong
Place of Incorporation Cayman Islands
Listing Category Primary Listing

a. Updating time-lag
The number of issued shares / issued units presented is generally updated within 7 days after the Monthly Returns and Next Day Disclosure Returns published by the listed issuers on the HKEXnews website. Hence, the information presented here may not be the most up-to-date information submitted by the listed issuers as required under the Listing Rules.
b. Rights issues or bonus issues
The number of issued shares / issued units presented here will be adjusted with effect from the ex-date in the event of announced rights issues or announced bonus issues. In this case, both the number of issued shares / issued units before and after the adjustment will be presented.
c. Share splits or share consolidations
The number of issued shares / issued units presented here will be adjusted on the effective date in the event of share splits or share consolidations.
d. Conversion of convertible notes into shares
If the change of the number of issued shares / issued units is due to conversion of convertible bonds, the number of issued shares / issued units presented here may be updated based on the related company announcement.
Updated: 24 Jul 2025 18:24 HKT
* Company profile is provided by Refinitiv.

ENTITLEMENT

Date Announced Ex-Date Details Financial Year End Book Close Date Payment date may be indicative only.Payment Date
31 Mar 2025-No Dividend for the period ended
2024/12/31
31 Dec 2024--
28 Aug 2024-No Dividend for the period ended
2024/06/30
31 Dec 2024--
28 Mar 2024-No Dividend for the period ended
2023/12/31
31 Dec 2023--
29 Aug 2023-No Dividend for the period ended
2023/06/30
31 Dec 2023--
21 Mar 2023-No Dividend for the period ended
2022/12/31
31 Dec 2022--
LOAD MORE
Updated: 25 Jul 2025 01:15 HKT
Dividend details are sourced from Announcement Forms published on HKEXnews